Katharina Buch

755 total citations
14 papers, 531 citations indexed

About

Katharina Buch is a scholar working on Psychiatry and Mental health, Neurology and Physiology. According to data from OpenAlex, Katharina Buch has authored 14 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Neurology and 7 papers in Physiology. Recurrent topics in Katharina Buch's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (6 papers) and Functional Brain Connectivity Studies (2 papers). Katharina Buch is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (6 papers) and Functional Brain Connectivity Studies (2 papers). Katharina Buch collaborates with scholars based in Germany, United States and Japan. Katharina Buch's co-authors include Alexander Kurz, Markus J. Riemenschneider, Frode Willoch, Satoshi Minoshima, Daniel J. Schad, Markus Schwaiger, Susanne Stübner, Markus Schwarz, Trey Sunderland and Michael Schmolke and has published in prestigious journals such as Brain Research, Neuroscience Letters and Dementia and Geriatric Cognitive Disorders.

In The Last Decade

Katharina Buch

13 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Buch Germany 10 323 251 130 125 70 14 531
J. O’Grady United Kingdom 12 199 0.6× 129 0.5× 152 1.2× 127 1.0× 64 0.9× 29 742
Norihiko Iwamoto Japan 14 267 0.8× 132 0.5× 118 0.9× 172 1.4× 73 1.0× 17 562
Beatriz Santiago Portugal 15 281 0.9× 200 0.8× 162 1.2× 151 1.2× 73 1.0× 32 673
Malene Jensen Sweden 10 469 1.5× 278 1.1× 89 0.7× 220 1.8× 54 0.8× 11 616
Liang‐Hao Guo Germany 18 363 1.1× 210 0.8× 189 1.5× 203 1.6× 51 0.7× 25 851
Fabian Corlier France 12 316 1.0× 226 0.9× 166 1.3× 122 1.0× 133 1.9× 17 626
Mari Blomberg Sweden 10 417 1.3× 316 1.3× 118 0.9× 186 1.5× 74 1.1× 12 648
Preeti Dave Australia 7 301 0.9× 205 0.8× 124 1.0× 152 1.2× 28 0.4× 9 508
M Alecci Italy 9 113 0.3× 174 0.7× 132 1.0× 97 0.8× 21 0.3× 15 595
Rüdiger Zimmermann Germany 9 300 0.9× 258 1.0× 77 0.6× 100 0.8× 44 0.6× 12 473

Countries citing papers authored by Katharina Buch

Since Specialization
Citations

This map shows the geographic impact of Katharina Buch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Buch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Buch more than expected).

Fields of papers citing papers by Katharina Buch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Buch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Buch. The network helps show where Katharina Buch may publish in the future.

Co-authorship network of co-authors of Katharina Buch

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Buch. A scholar is included among the top collaborators of Katharina Buch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Buch. Katharina Buch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hampel, Harald, Frank Padberg, Katharina Buch, et al.. (2008). Diagnose und Therapie der Demenz vom Alzheimer-Typ. DMW - Deutsche Medizinische Wochenschrift. 124(5). 124–129.
2.
3.
Stübner, Susanne, Frank Padberg, Stefan Teipel, et al.. (1999). Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neuroscience Letters. 259(3). 145–148. 49 indexed citations
4.
Buch, Katharina, Frank Padberg, Stefan Teipel, et al.. (1999). Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls. Neuroscience Letters. 277(1). 21–24. 49 indexed citations
5.
Hampel, Harald, et al.. (1998). A review of the reversible MAO-A inhibitor moclobemide in geriatric patients. Human Psychopharmacology Clinical and Experimental. 13(1). 43–51. 3 indexed citations
6.
Riemenschneider, Markus J., Katharina Buch, Frode Willoch, et al.. (1998). Tau Protein in Cerebrospinal Fluid Is Significantly Increased at the Earliest Clinical Stage of Alzheimer Disease. Alzheimer Disease & Associated Disorders. 12(4). 372–377. 61 indexed citations
7.
Buch, Katharina, Markus J. Riemenschneider, Peter Bartenstein, et al.. (1998). Tau-Protein. Der Nervenarzt. 69(5). 379–385. 12 indexed citations
8.
Buch, Katharina, et al.. (1998). Morbus Sudeck - Pathologie, Klinik und Therapie. Sportverletzung · Sportschaden. 12(2). 79–85. 1 indexed citations
9.
Hampel, Harald, Markus Schwarz, Trey Sunderland, et al.. (1997). Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neuroscience Letters. 228(3). 143–146. 46 indexed citations
10.
Bartenstein, Peter, Satoshi Minoshima, Frode Willoch, et al.. (1997). Reduction of Regional Cerebral Blood Flow and Cognitive Impairment in Patients with Alzheimer's Disease: Evaluation of an Observer-Independent Analytic Approach. Dementia and Geriatric Cognitive Disorders. 8(2). 98–104. 40 indexed citations
11.
Bartenstein, Peter, Satoshi Minoshima, Katharina Buch, et al.. (1997). Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.. PubMed. 38(7). 1095–101. 119 indexed citations
12.
Schmolke, Michael, et al.. (1997). Protein tau — A marker for “early forms” of Alzheimer's Disease. European Psychiatry. 12(S2). 179s–179s. 1 indexed citations
13.
Riemenschneider, Markus J., et al.. (1996). Cerebrospinal protein tau is elevated in early Alzheimer's disease. Neuroscience Letters. 212(3). 209–211. 68 indexed citations
14.
Martinꝉ, Roland, U. Schwuléra, G. Menke, et al.. (1992). Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administration.. PubMed. 3(4). 399–406. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. O’Grady Breakdown of academic impact, for papers by Norihiko Iwamoto Breakdown of academic impact, for papers by Beatriz Santiago Breakdown of academic impact, for papers by Malene Jensen Breakdown of academic impact, for papers by Liang‐Hao Guo Breakdown of academic impact, for papers by Fabian Corlier Breakdown of academic impact, for papers by Mari Blomberg Breakdown of academic impact, for papers by Preeti Dave Breakdown of academic impact, for papers by M Alecci Breakdown of academic impact, for papers by Rüdiger Zimmermann
Rankless by CCL
2026